|
1
|
Greve MW and Zink BJ: Pathophysiology of
traumatic brain injury. Mt Sinai J Med. 76:97–104. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Helmy A, De Simoni MG, Guilfoyle MR,
Carpenter KL and Hutchinson PJ: Cytokines and innate inflammation
in the pathogenesis of human traumatic brain injury. Prog
Neurobiol. 95:352–372. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ziebell JM and Morganti-Kossmann MC:
Involvement of pro- and anti-inflammatory cytokines and chemokines
in the pathophysiology of traumatic brain injury.
Neurotherapeutics. 7:22–30. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kopp E and Medzhitov R: Recognition of
microbial infection by Toll-like receptors. Curr Opin Immunol.
15:396–401. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fang H, Wang PF, Zhou Y, Wang YC and Yang
QW: Toll-like receptor 4 signaling in intracerebral
hemorrhage-induced inflammation and injury. J Neuroinflammation.
10:272013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhu HT, Bian C, Yuan JC, Chu WH, Xiang X,
Chen F, Wang CS, Feng H and Lin JK: Curcumin attenuates acute
inflammatory injury by inhibiting the TLR4/MyD88/NF-κB signaling
pathway in experimental traumatic brain injury. J
Neuroinflammation. 11:592014. View Article : Google Scholar
|
|
7
|
Ahmad A, Crupi R, Campolo M, Genovese T,
Esposito E and Cuzzocrea S: Absence of TLR4 reduces neurovascular
unit and secondary inflammatory process after traumatic brain
injury in mice. PLoS One. 8:e572082013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li GZ, Zhang Y, Zhao JB, Wu GJ, Su XF and
Hang CH: Expression of myeloid differentiation primary response
protein 88 (Myd88) in the cerebral cortex after experimental
traumatic brain injury in rats. Brain Res. 1396:96–104. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang X, Stridh L, Li W, Dean J, Elmgren A,
Gan L, Eriksson K, Hagberg H and Mallard C: Lipopolysaccharide
sensitizes neonatal hypoxic-ischemic brain injury in a
MyD88-dependent manner. J Immunol. 183:7471–7477. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pozuelo-Rubio M: 14-3-3ζ binds class III
phosphatidylinositol-3-kinase and inhibits autophagy. Autophagy.
7:240–242. 2011. View Article : Google Scholar
|
|
11
|
Bursch W, Hochegger K, Torok L, Marian B,
Ellinger A and Hermann RS: Autophagic and apoptotic types of
programmed cell death exhibit different fates of cytoskeletal
filaments. J Cell Sci. 113:1189–1198. 2000.PubMed/NCBI
|
|
12
|
Luo CL, Li BX, Li QQ, Chen XP, Sun YX, Bao
HJ, Dai DK, Shen YW, Xu HF, Ni H, et al: Autophagy is involved in
traumatic brain injury-induced cell death and contributes to
functional outcome deficits in mice. Neuroscience. 184:54–63. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bao HJ, Zhang L, Han WC and Dai DK:
Apelin-13 attenuates traumatic brain injury-induced damage by
suppressing autophagy. Neurochem Res. 40:89–97. 2015. View Article : Google Scholar
|
|
14
|
Cui C, Cui Y, Gao J, Sun L, Wang Y, Wang
K, Li R, Tian Y, Song S and Cui J: Neuroprotective effect of
ceftriaxone in a rat model of traumatic brain injury. Neurol Sci.
35:695–700. 2014. View Article : Google Scholar
|
|
15
|
Xu Y, Jagannath C, Liu XD, Sharafkhaneh A,
Kolodziejska KE and Eissa NT: Toll-like receptor 4 is a sensor for
autophagy associated with innate immunity. Immunity. 27:135–144.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Seay MD and Dinesh-Kumar SP: Autophagy
takes its TOLL on innate immunity. Cell Host Microbe. 2:69–70.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xu Y, Liu XD, Gong X and Eissa NT:
Signaling pathway of autophagy associated with innate immunity.
Autophagy. 4:110–112. 2008. View Article : Google Scholar
|
|
18
|
Ates O, Cayli S, Altinoz E, Gurses I,
Yucel N, Sener M, Kocak A and Yologlu S: Neuroprotection by
resveratrol against traumatic brain injury in rats. Mol Cell
Biochem. 294:137–144. 2007. View Article : Google Scholar
|
|
19
|
Gatson JW, Liu MM, Abdelfattah K,
Wigginton JG, Smith S, Wolf S and Minei JP: Resveratrol decreases
inflammation in the brain of mice with mild traumatic brain injury.
J Trauma Acute Care Surg. 74:470–475. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lin CJ, Chen TH, Yang LY and Shih CM:
Resveratrol protects astrocytes against traumatic brain injury
through inhibiting apoptotic and autophagic cell death. Cell Death
Dis. 5:e11472014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Alayev A, Sun Y, Snyder RB, Berger SM, Yu
JJ and Holz MK: Resveratrol prevents rapamycin-induced upregulation
of autophagy and selectively induces apoptosis in TSC2-deficient
cells. Cell Cycle. 13:371–382. 2014. View
Article : Google Scholar :
|
|
22
|
Zhang C, Lin G, Wan W, Li X, Zeng B, Yang
B and Huang C: Resveratrol, a polyphenol phytoalexin, protects
cardiomyocytes against anoxia/reoxygenation injury via the
TLR4/NF-κB signaling pathway. Int J Mol Med. 29:557–563.
2012.PubMed/NCBI
|
|
23
|
Liu L, Gu H, Liu H, Jiao Y, Li K, Zhao Y,
An L and Yang J: Protective effect of resveratrol against
IL-1β-induced inflammatory response on human osteoarthritic
chondrocytes partly via the TLR4/MyD88/NF-κB signaling pathway: an
'in vitro study'. Int J Mol Sci. 15:6925–6940. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mahmood A, Lu D and Chopp M: Marrow
stromal cell transplantation after traumatic brain injury promotes
cellular proliferation within the brain. Neurosurgery.
55:1185–1193. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sönmez U, Sönmez A, Erbil G, Tekmen I and
Baykara B: Neuroprotective effects of resveratrol against traumatic
brain injury in immature rats. Neurosci Lett. 420:133–137. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shao AW, Wu HJ, Chen S, Ammar AB, Zhang JM
and Hong Y: Resveratrol attenuates early brain injury after
subarachnoid hemorrhage through inhibition of NF-κB-dependent
inflammatory/MMP-9 pathway. CNS Neurosci Ther. 20:182–185. 2014.
View Article : Google Scholar
|
|
27
|
Leker RR and Shohami E: Cerebral ischemia
and trauma-different etiologies yet similar mechanisms:
neuroprotective opportunities. Brain Res Brain Res Rev. 39:55–73.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bramlett HM and Dietrich WD:
Pathophysiology of cerebral ischemia and brain trauma: Similarities
and differences. J Cereb Blood Flow Metab. 24:133–150. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yatsiv I, Grigoriadis N, Simeonidou C,
Stahel PF, Schmidt OI, Alexandrovitch AG, Tsenter J and Shohami E:
Erythropoietin is neuroprotective, improves functional recovery,
and reduces neuronal apoptosis and inflammation in a rodent model
of experimental closed head injury. FASEB J. 19:1701–1703.
2005.PubMed/NCBI
|
|
30
|
Singleton RH, Yan HQ, Fellows-Mayle W and
Dixon CE: Resveratrol attenuates behavioral impairments and reduces
cortical and hippocampal loss in a rat controlled cortical impact
model of traumatic brain injury. J Neurotrauma. 27:1091–1099. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sarkar C, Zhao Z, Aungst S, Sabirzhanov B,
Faden AI and Lipinski MM: Impaired autophagy flux is associated
with neuronal cell death after traumatic brain injury. Autophagy.
10:2208–2222. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lipinski MM, Wu J, Faden AI and Sarkar C:
Function and mechanisms of autophagy in brain and spinal cord
trauma. Antioxid Redox Signal. 23:565–577. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Shimizu S, Kanaseki T, Mizushima N, Mizuta
T, Arakawa-Kobayashi S, Thompson CB and Tsujimoto Y: Role of Bcl-2
family proteins in a non-apoptotic programmed cell death dependent
on autophagy genes. Nat Cell Biol. 6:1221–1228. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Shi R, Weng J, Zhao L, Li XM, Gao TM and
Kong J: Excessive autophagy contributes to neuron death in cerebral
ischemia. CNS Neurosci Ther. 18:250–260. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sun LQ, Gao JL, Cui CM, Cui Y, Jing XB,
Zhao MM, Wang YC, Tian YX, Wang KJ and Cui JZ: Astrocytic
p-connexin 43 regulates neuronal autophagy in the hippocampus
following traumatic brain injury in rats. Mol Med Rep. 9:77–82.
2014.
|
|
36
|
Alayev A, Berger SM, Kramer MY, Schwartz
NS and Holz MK: The combination of rapamycin and resveratrol blocks
autophagy and induces apoptosis in breast cancer cells. J Cell
Biochem. 116:450–457. 2015. View Article : Google Scholar :
|
|
37
|
Chang YP, Ka SM, Hsu WH, Chen A, Chao LK,
Lin CC, Hsieh CC, Chen MC, Chiu HW, Ho CL, et al: Resveratrol
inhibits NLRP3 inflammasome activation by preserving mitochondrial
integrity and augmenting autophagy. J Cell Physiol. 230:1567–1579.
2015. View Article : Google Scholar
|
|
38
|
Wang B, Yang Q, Sun YY, Xing YF, Wang YB,
Lu XT, Bai WW, Liu XQ and Zhao YX: Resveratrol-enhanced autophagic
flux ameliorates myocardial oxidative stress injury in diabetic
mice. J Cell Mol Med. 18:1599–1611. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Han KJ, Su X, Xu LG, Bin LH, Zhang J and
Shu HB: Mechanisms of the TRIF-induced interferon-stimulated
response element and NF-kappaB activation and apoptosis pathways. J
Biol Chem. 279:15652–15661. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Baumgarten G, Knuefermann P, Nozaki N,
Sivasubramanian N, Mann DL and Vallejo JG: In vivo expression of
proinflammatory mediators in the adult heart after endotoxin
administration: the role of Toll-like receptor-4. J Infect Dis.
183:1617–1624. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
41
|
Youn HS, Lee JY, Fitzgerald KA, Young HA,
Akira S and Hwang DH: Specific inhibition of MyD88-independent
signaling pathways of TLR3 and TLR4 by resveratrol: molecular
targets are TBK1 and RIP1 in TRIF complex. J Immunol.
175:3339–3346. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Li J, Xie C, Zhuang J, Li H, Yao Y, Shao C
and Wang H: Resveratrol attenuates inflammation in the rat heart
subjected to ischemia-reperfusion: role of the TLR4/NF-κB signaling
pathway. Mol Med Rep. 11:1120–1126. 2015.
|
|
43
|
Zhen L, Fan DS, Zhang Y, Cao XM and Wang
LM: Resveratrol ameliorates experimental periodontitis in diabetic
mice through negative regulation of TLR4 signaling. Acta Pharmacol
Sin. 36:221–228. 2015. View Article : Google Scholar :
|
